Skip to main content
. 2014 Aug 1;3(8):511–529. doi: 10.1089/wound.2012.0401

Figure 4.

Figure 4.

(A) Regranex® (Healthpoint Biotherapeutics, Arlington, TX), a platelet-derived growth factor therapy that utilizes an amorphous hydrogel as a vehicle for its active ingredient, being applied to a sacral decubitus ulcer. (B) Flexigel (Smith and Nephew) hydrogel flexible sheet dressing applied to a nonhealing wound of the lower breast. To see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/wound